Artelo Biosciences Inc (NASDAQ: ARTL) on Monday, soared 42.49% from the previous trading day, before settling in for the closing price of $10.05. Within the past 52 weeks, ARTL’s price has moved between $4.92 and $25.58.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Over the past five-year period, the drop rate of yearbook sales for the company of the Healthcare sector was -24.98%. The company achieved an average annual earnings per share of -81.64%. With a float of $0.68 million, this company’s outstanding shares have now reached $3.28 million.
Considering the fact that the conglomerate employs 6 people, you should pay attention to its efficiency factor. In terms of profitability, gross margin is 0.0%, operating margin of 0.0%, and the pretax margin is 0.0%.
Artelo Biosciences Inc (ARTL) Insider Activity
Observing investor behavior towards Biotechnology industry stocks is more important than anything else. The insider ownership of Artelo Biosciences Inc is 0.83%, while institutional ownership is 2.11%.
Artelo Biosciences Inc (ARTL) Earnings and Forecasts
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.84 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around -81.64% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 43.16% during the next five years compared to -24.98% drop over the previous five years of trading.
Artelo Biosciences Inc (NASDAQ: ARTL) Trading Performance Indicators
Artelo Biosciences Inc (ARTL) is currently performing well based on its current performance indicators. A quick ratio of 0.34 was reported for the most recent quarter.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -2.99, a number that is poised to hit -25.14 in the next quarter and is forecasted to reach -6.30 in one year’s time.
Technical Analysis of Artelo Biosciences Inc (ARTL)
Compared to the last year’s volume of 0.32 million, its volume of 7.07 million showed improvement in the last five days. As of the previous 9 days, the stock’s Stochastic %D was 28.83%.
During the past 100 days, Artelo Biosciences Inc’s (ARTL) raw stochastic average was set at 45.50%, which indicates a significant increase from 43.19% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 357.88% in the past 14 days, which was higher than the 152.90% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $6.74, while its 200-day Moving Average is $6.62. Nevertheless, the first resistance level for the watch stands at $20.79 in the near term. At $27.26, the stock is likely to face the second major resistance level. The third major resistance level sits at $31.00. If the price goes on to break the first support level at $10.58, it is likely to go to the next support level at $6.84. Should the price break the second support level, the third support level stands at $0.37.
Artelo Biosciences Inc (NASDAQ: ARTL) Key Stats
Market capitalization of the company is 9.79 million based on 547K outstanding shares. Right now, sales total 0 K and income totals -9,830 K. The company made 0 K in profit during its latest quarter, and -2,370 K in sales during its previous quarter.
